Federal Agency for Medicines and Health Products (FAMHP) famhp.be

Jascayd

Imported from official source

October 08, 2026 07:09 Announcement

Safety Classified by Officially

Jascayd Active substance Nerandomilast Holder Boehringer Ingelheim International GmbH Status Running Indication Treatment of adult patients with progressive pulmonary fibrosis Public documents Approbation Information for the patient Informed consent Last update 08/10/2026 valerie.coqu Thu, 10/08/2026 - 09:22

Read the original at the source: https://www.famhp.be/fr/usage_humain/medicaments/medicaments/recherche_developpement/usage_compassionnel_programmes_135

Officially imported this from Federal Agency for Medicines and Health Products (FAMHP)’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization: Federal Agency for Medicines and Health Products (FAMHP) — imported from official source
Official source: https://www.famhp.be/en/rss.xml RSS
Imported: October 08, 2026 07:34
Versions: 1 recorded
Identity: 110406 at https://www.famhp.be